EYPT
EyePoint, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
−3.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 424.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.99x
- Price / sales
- 119.01x
- Price / cash flow
- -1.24x
Enterprise value
- Enterprise value
- $173.8M
- EV / sales
- 62.32x
- EV / EBITDA
- -0.59x
- EV / EBIT
- -0.55x
- Market cap
- $331.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026